Tributyltin inhibits autophagy by decreasing lysosomal acidity in SH-SY5Y cells.
Autophagosomes
/ drug effects
Autophagy
/ drug effects
Cell Line, Tumor
Cell Survival
/ drug effects
Humans
Hydrolysis
Intracellular Membranes
/ drug effects
Lysosomes
/ drug effects
Microtubule-Associated Proteins
/ metabolism
Sequestosome-1 Protein
/ metabolism
Trialkyltin Compounds
/ pharmacology
Autophagy
Lysosome
Tributyltin
Journal
Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516
Informations de publication
Date de publication:
12 02 2022
12 02 2022
Historique:
received:
10
12
2021
revised:
13
12
2021
accepted:
30
12
2021
pubmed:
12
1
2022
medline:
11
2
2022
entrez:
11
1
2022
Statut:
ppublish
Résumé
Tributyltin (TBT) is an environmental pollutant that remains in marine sediments and is toxic to mammals. For example, TBT elicits neurotoxic and immunosuppressive effects on rats. However, it is not entirely understood how TBT causes toxicity. Autophagy plays a pivotal role in protein quality control and eliminates aggregated proteins and damaged organelles. We previously reported that TBT dephosphorylates mammalian target of rapamycin (mTOR), which may be involved in enhancement of autophagosome synthesis, in primary cultures of cortical neurons. Autophagosomes can accumulate due to enhancement of autophagosome synthesis or inhibition of autophagic degradation, and we did not clarify whether TBT alters autophagic flux. Here, we investigated the mechanism by which TBT causes accumulation of autophagosomes in SH-SY5Y cells. TBT inhibited autophagy without affecting autophagosome-lysosome fusion before it caused cell death. TBT dramatically decreased the acidity of lysosomes without affecting lysosomal membrane integrity. TBT decreased the mature protein level of cathepsin B, and this may be related to the decrease in lysosomal acidity. These results suggest that TBT inhibits autophagic degradation by decreasing lysosomal acidity. Autophagy impairment may be involved in the mechanism underlying neuronal death and/or T-cell-dependent thymus atrophy induced by TBT.
Identifiants
pubmed: 35016149
pii: S0006-291X(21)01769-1
doi: 10.1016/j.bbrc.2021.12.118
pii:
doi:
Substances chimiques
MAP1LC3A protein, human
0
Microtubule-Associated Proteins
0
SQSTM1 protein, human
0
Sequestosome-1 Protein
0
Trialkyltin Compounds
0
tributyltin
4XDX163P3D
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
31-37Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.